Thalidomide analogue DAID safely and effectively reduces ocular neovascularization in rats Oct. 10, 2018 No Comments
A new model of persistent retinal neovascularization better reflects the human disease phenotype Oct. 2, 2018 No Comments
Ocugen initiates the first trial in its phase III program of OCU-310 in dry eye disease Oct. 2, 2018 No Comments